Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) CEO Daniel O’Day sold 15,881 shares of the firm’s stock in a transaction on Friday, October 30th. The stock was sold at an average price of $175.25, for a total value of $2,783,145.25. Following the completion of the sale, the chief executive officer directly owned 566,683 shares […]